Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features

OBJECTIVE: The use of a neoadjuvant chemoradiation followed by surgery in patients with stage IIIA NSCLC is controversial and the benefit of surgery is limited. There are currently no clinically validated biomarkers to select patients for such an approach. In this study we evaluate computed tomograp...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Lung Cancer
Main Authors: Khorrami, Mohammadhadi, Jain, Prantesh, Bera, Kaustav, Patil, Pradnya, Ahmad, Usman, Murthy, Sudish, Stephans, Kevin, Fu, Pingfu, Velcheti, Vamsidhar, Madabhushi, Anant
פורמט: Artigo
שפה:Inglês
יצא לאור: 2019
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6711393/
https://ncbi.nlm.nih.gov/pubmed/31446979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2019.06.020
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים